Cancer News and Research

Latest Cancer News and Research

University of Leicester biochemist to present research on the functions of stem cells in the intestine

A University of Leicester Biochemist will present her research on the functions of stem cells in the intestine at a free public lecture.

12 Oct 2009

Wake Forest University School of Medicine honours researchers

Wake Forest University School of Medicine honored eight of its researchers with awards for excellence at the 13th Annual Research Awards Day Oct. 1.

12 Oct 2009

Santarus and Norgine enter into a licensing agreement for ZEGERID products

Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.

12 Oct 2009

GE Healthcare launches global initiative to celebrate 10th anniversary of digital mammography

GE Healthcare (NYSE:GE) wishes to issue the following update and correction to its release NewsItemID 20090923005515 (GE-HEALTHCARE) "GE Healthcare Launches Global Initiative to Celebrate the 10th Anniversary of Digital Mammography" issued September 23, 2009/

12 Oct 2009

InTouch Health to feature at FiReGlobal's conference

FiReGlobal : West Coast is proud to announce that InTouch Health has been selected as a FiReStar company to be featured at the FiReGlobal : West Coast conference.

12 Oct 2009

The third “Exciting Biologies” meeting focuses on “Biology In Balance”

In a continuing series called “Exciting Biologies” Cell Press, Massachusetts General Hospital and La Fondation Ipsen collaborate to offer annual meetings designed to highlight emerging intersections in biomedical research and promote interactions between scientists from converging disciplines. This third meeting, held in Buenos Aires between the 8th and 10th of October, focused on “Biology in Balance”.

12 Oct 2009

First evidence that personalized medicine leads to better outcomes

A statistical model can accurately predict which patients will have poor outcomes after bladder surgery and can determine the need for chemotherapy.

12 Oct 2009

Breast cancer patients who achieve pathological complete response have better outcomes

Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center.

12 Oct 2009

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.

12 Oct 2009

Nektar Therapeutics presents the results from Phase 2 clinical trial of oral NKTR-118

Nektar Therapeutics presented topline data today from its Phase 2 clinical trial of oral NKTR-118 at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting in Phoenix, Arizona.

12 Oct 2009

Vaccination against HPV will help decrease cervical cancer death rate in India

Although a wide spectrum of human papillomavirus is seen across the population of India, HPV-16 and HPV-18 are the most common types and a vaccination targeting these types could eliminate 75 percent of the cervical cancers in the region, according to data presented at the American Association for Cancer Research Frontiers in Basic Cancer Research Meeting.

12 Oct 2009

Federal stimulus funds for comparative-effectiveness research in cancer

Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.

12 Oct 2009

Pieris reports its progress in the development of PRS-050

Pieris AG, the biopharmaceutical company developing Anticalins as a novel class of targeted human protein therapeutics, today reported continued progress in development of its lead therapeutic program for the clinic.

12 Oct 2009

Researchers find how KEAP1 tumor suppressor works

A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell.

12 Oct 2009

Findings may reveal new treatments for people suffering from chronic hemoglobin levels

A gene with a significant effect on regulating hemoglobin in the body has been identified as part of a genome-wide association study, which looked at the link between genes and hemoglobin level in 16,000 people.

12 Oct 2009

Socioeconomic and geographic disparities in the use of breast-conservating therapy

According to a new study published in the October issue of the Journal of the American College of Surgeons, although breast-conserving surgery (BCS), commonly known as lumpectomy, is increasingly being used to treat older women with nonmetastatic invasive breast cancer, there are still significant socioeconomic and geographic disparities in the use of this type of therapy.

12 Oct 2009

Dilon Diagnostics and Philips sign distribution agreement

Dilon Diagnostics, the leader in molecular breast imaging (MBI) also known as Breast-Specific Gamma Imaging (BSGI) and Philips (NYSE: PHG, AEX: PHI), today announce that they have entered into a distribution agreement. Philips Healthcare will sell and support the Dilon 6800 gamma camera in key European and Middle Eastern markets. The compact camera technology and related products and services are used for the detection of breast cancer as an adjunct to mammography and serve to complement Philips innovative women's health solutions.

12 Oct 2009

Sahlgrenska researchers identify special protein that defends against stomach ulcer bacterium

A special protein in the lining of the stomach has been shown to be an important part of the body's defence against the stomach ulcer bacterium Helicobacter pylori in a new study from the Sahlgrenska Academy at the University of Gothenburg. The discovery may explain why the bacterium makes some people more ill than others.

12 Oct 2009

M. D. Anderson Cancer Center researchers announce study results of treatment for rare pediatric brain cancer

A team of researchers led by The University of Texas M. D. Anderson Cancer Center unveiled results today from the largest-ever collaborative study addressing the treatment of a rare pediatric brain tumor. The findings suggest a new standard protocol could improve survival nearly two-fold for pediatric patients with choroid plexus tumors, as reported at the 41st Annual Meeting of the International Society of Pediatric Oncology (SIOP).

12 Oct 2009

PPA bus tour to raise awareness of patient assistance programs

The 'Help is Here Express' bus tour will be stopping in Iowa, Southern Illinois, and Southern Indiana throughout the week of October 12 -- 16th at various cities in order to help uninsured and financially-struggling Midwesterners access information on programs that provide prescription medicines for free or nearly free.

12 Oct 2009

Cancer News and Research

Latest Cancer News and Research

University of Leicester biochemist to present research on the functions of stem cells in the intestine

Wake Forest University School of Medicine honours researchers

Santarus and Norgine enter into a licensing agreement for ZEGERID products

GE Healthcare launches global initiative to celebrate 10th anniversary of digital mammography

InTouch Health to feature at FiReGlobal's conference

The third “Exciting Biologies” meeting focuses on “Biology In Balance”

First evidence that personalized medicine leads to better outcomes

Breast cancer patients who achieve pathological complete response have better outcomes

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Nektar Therapeutics presents the results from Phase 2 clinical trial of oral NKTR-118

Vaccination against HPV will help decrease cervical cancer death rate in India

Federal stimulus funds for comparative-effectiveness research in cancer

Pieris reports its progress in the development of PRS-050

Researchers find how KEAP1 tumor suppressor works

Findings may reveal new treatments for people suffering from chronic hemoglobin levels

Socioeconomic and geographic disparities in the use of breast-conservating therapy

Dilon Diagnostics and Philips sign distribution agreement

Sahlgrenska researchers identify special protein that defends against stomach ulcer bacterium

M. D. Anderson Cancer Center researchers announce study results of treatment for rare pediatric brain cancer

PPA bus tour to raise awareness of patient assistance programs

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Cancer News and Research

Latest Cancer News and Research

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in